$28.12−0.40 (−1.40%)
At close: Oct 1, 2026, 4:00 PM ET
$28.13+0.01 (+0.04%)
After hours: Oct 1, 2026, 7:39 PM ET
Pfizer Inc. · Overview
Industry: Drugs · see every company filed here →
Pfizer Inc. scores 50/100. Mixed. Strongest on value, financial health is the soft spot, trading at 37× earnings versus 400 Healthcare peers.
Tenet Score · vs sector
n=400Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value69
Quality64
Health23
Growth45
Factor grades
Grid rings: 25 · 50 · 75 · 100 percentile
ValueCQualityCHealthFGrowthDMomentumC
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Price
Loading chart…
P/E
37.0×
price ÷ trailing EPS, Oct 1, 2026 close
P/B
1.9×
cap ÷ Jun 28, 2026 book value, Oct 1, 2026 close
P/S
2.6×
price to fiscal 2025 sales
ROE
5%
TTM through Jun 28, 2026
Operating margin
22.8%
fiscal 2025, before interest and tax
Net margin
6.9%
TTM through Jun 28, 2026
Current ratio
1.27
Jun 28, 2026 balance sheet
Net debt / EBITDA
2.5×Tenet-derived Total debt less cash and short-term investments, over EBITDA (operating income plus depreciation and amortisation) from the filed statements. Long-term investments are not counted as cash. For some companies they include marketable securities held for more than a year. Computed by Tenet from the filed statements (formula house-nde.v1), because the data vendor published no value for this year.
computed by Tenet from the filed statements
EPS CAGR 5y
−3.6%
trailing 5-year, per share
Market cap
$160.4B
large cap
Div yield
6.12%
fiscal-year dividend ÷ price
52-wk range
23.62 – 29.21
low → high
Market cap: share price × the latest quarter's diluted weighted-average share count (vendor).
The whole report, at a glance · every card is a live peek, click any to open the section
Tenets
4 / 17
- ✕ Buffett Quality
- ~ Piotroski F-Score
- ✕ Munger Compounders
- ✓ Magic Formula
- ✕ Graham Defensive
- ~ Income & Dividend Safety
+11 more →
Financials
Revenue, margins and the five-year statements.Analyst Forecasts
Consensus estimates are on the Analyst tab.
Earnings
Report dates and the beat-versus-miss record.Statistics
ROIC9%
Gross margin73%
Debt / equity0.74
Technical Analysis
Uptrend short-term signalvs 50-day+3.1%
vs 200-day+6.5%
RSI (14)53
News & Insights
Headlines are on the News tab.Dividends
6.12% yield
Pays 6.12% · 125% of earnings. Yield is one component of total return.
Ownership
70% institutional
13F flows & insider trades land here.
About Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin fami…
Composite computed 2026-10-02 · peer basis: Healthcare (n=400) · every glimpse links to its full section with sources · not investment advice.
ETF exposure
Free account: the funds that hold PFE, and at what weight. Everything else on this page stays open.Create a free account